Literature DB >> 28104781

Reconsidering Prostate Cancer Screening.

Charlie Schmidt1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28104781      PMCID： PMC6284255          DOI： 10.1093/jnci/djw337

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  2 in total

1.  Soluble CD105 is prognostic of disease recurrence in prostate cancer patients.

Authors:  Veronica R Placencio-Hickok; Anisha Madhav; Sungjin Kim; Frank Duong; Bryan Angara; Zhenqiu Liu; Neil A Bhowmick
Journal:  Endocr Relat Cancer       Date:  2020-01       Impact factor: 5.678

2.  Prostate-specific antigen screening: An update of physician beliefs and practices.

Authors:  Ingrid J Hall; Sun Hee Rim; Greta M Massetti; Cheryll C Thomas; Jun Li; Lisa C Richardson
Journal:  Prev Med       Date:  2017-08-06       Impact factor: 4.018
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.